• 1
    Bearman GM, WenzelRP.Bacteremias: a leading cause of death. Arch Med Res 2005; 36: 646659.
  • 2
    Tumbarello M, TacconelliE, CaponeraS, CaudaR, OrtonaL.The impact of bacteraemia on HIV infection. Nine years experience in a large Italian university hospital. J Infect1995; 31: 123131.
  • 3
    Fichtenbaum CJ, DunaganWC, PowderlyWG.Bacteremia in hospitalized patients infected with the human immunodeficiency virus: a case-control study of risk factors and outcome. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8: 5157.
  • 4
    Senthilkumar A, KumarS, SheagrenJN.Increased incidence of Staphylococcus aureus bacteremia in hospitalized patients with acquired immunodeficiency syndrome. Clin Infect Dis2001; 33: 14121416.
  • 5
    Laupland KB, ChurchDL, MucenskiM, SutherlandLR, DaviesHD.Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections. J Infect Dis2003; 187: 14521459.
  • 6
    Craven DE. Staphylococcus aureus colonisation and bacteraemia in persons infected with human immunodeficiency virus: a dynamic interaction with the host. J Chemother 1995; 7(Suppl 3): 1928.
  • 7
    Weinke T, SchillerR, FehrenbachFJ, PohleHD.Association between Staphylococcus aureus nasopharyngeal colonization and septicemia in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis1992; 11: 985989.
  • 8
    Nguyen MH, KauffmanCA, GoodmanRPet al. Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients. Ann Intern Med1999; 130: 221225.
  • 9
    Manfredi R, CostigliolaP, RicchiE, ChiodoF.Sepsis-bacteraemia and other infections due to non-opportunistic bacterial pathogens in a consecutive series of 788 patients hospitalized for HIV infection. Clin Ther1993; 143: 279290.
  • 10
    Nicastri E, PetrosilloN, VialeP, IppolitoG.Catheter-related bloodstream infections in HIV-infected patients. Ann NY Acad Sci2001; 946: 274290.
  • 11
    Lark RL, ChenowethC, SaintS, ZemencukJK, LipskyBA, PlordeJJ.Four year prospective evaluation of nosocomial bacteremia: epidemiology, microbiology, and patient outcome. Diagn Microbiol Infect Dis 2000; 38: 131140.
  • 12
    Lambotte O, LucetJC, FleuryL, Joly-GuillouML, BouvetE.Nosocomial bacteremia in HIV patients: the role of peripheral venous catheters. Infect Control Hosp Epidemiol 2000; 21: 330333.
  • 13
    Kreisel K, BoydK, LangenbergP, RoghmannMC.Risk factors for recurrence in patients with Staphylococcus aureus infections complicated by bacteremia. Diagn Microbiol Infect Dis2006; 55: 179184.
  • 14
    Pedro-Botet ML, ModolJM, VallesXet al. Changes in bloodstream infections in HIV-positive patients in a university hospital in Spain (1995–1997). Int J Infect Dis2002; 6: 1722.
  • 15
    Mocroft A, LedergerberB, KatlamaCet al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 2003; 362: 2229.
  • 16
    Benfield T, EspersenF, Frimodt-MollerNet al. Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000. Clin Microbiol Infect2007; 13: 257263.
  • 17
    Statistics Denmark. Population in Denmark, January 1st 2007. Available at Accessed 1 March 2010.
  • 18
    Lohse N, HansenAB, Jensen-FangelSet al. Demographics of HIV-1 infection in Denmark: results from the Danish HIV Cohort Study. Scand J Infect Dis 2005; 37: 338343.
  • 19
    Pedersen CB, GotzscheH, MollerJO, MortensenPB.The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull2006; 53: 441449.
  • 20
    Jessen O, RosendalK, BulowP, FaberV, EriksenKR.Changing staphylococci and staphylococcal infections. A ten-year study of bacteria and cases of bacteremia. N Engl J Med1969; 281: 627635.
  • 21
    Frimodt-Moller N, EspersenF, SkinhojP, RosdahlVT.Epidemiology of Staphylococcus aureus bacteremia in Denmark from 1957 to 1990. Clin Microbiol Infect1997; 3: 297305.
  • 22
    Obel N, EngsigFN, RasmussenLD, LarsenMV, OmlandLH, SorensenHT.Cohort profile: The Danish HIV Cohort Study. Int J Epidemiol 2009; 38: 12021206.
  • 23
    Rostgaard K. Methods for stratification of person-time and events – a prerequisite for Poisson regression and SIR estimation. Epidemiol Perspect Innov2008; 5: 7.
  • 24
    Laupland KB, RossT, GregsonDB.Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000–2006. J Infect Dis 2008; 198: 336343.
  • 25
    Mocroft A, PhillipsAN, GatellJet al. Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study. Lancet 2007; 370: 407413.
  • 26
    Meynard JL, GuiguetM, FonquernieLet al. Impact of highly active antiretroviral therapy on the occurrence of bacteraemia in HIV-infected patients and their epidemiologic characteristics. HIV Med2003; 4: 127132.
  • 27
    Tumbarello M, TacconelliE, DonatiKGet al. HIV-associated bacteremia: how it has changed in the highly active antiretroviral therapy (HAART) era. J Acquir Immune Defic Syndr 2000; 23: 145151.
  • 28
    Burkey MD, WilsonLE, MooreRD, LucasGM, FrancisJ, GeboKA.The incidence of and risk factors for MRSA bacteraemia in an HIV-infected cohort in the HAART era. HIV Med2008; 9: 858862.
  • 29
    Tumbarello M, de GaetanoDK, TacconelliEet al. Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in HIV-infected patients. J Antimicrob Chemother2002; 50: 375382.
  • 30
    Mathews WC, CapernaJC, BarberREet al. Incidence of and risk factors for clinically significant methicillin-resistant Staphylococcus aureus infection in a cohort of HIV-infected adults. J Acquir Immune Defic Syndr2005; 40: 155160.
  • 31
    Liang SH, LoYC, LinHHet al. Seroprevalence of viral hepatitis and infectious complications among human immunodeficiency virus-infected injection drug users at a referral hospital. J Microbiol Immunol Infect2008; 41: 200208.
  • 32
    Popovich KJ, WeinsteinRA, AroutchevaA, RiceT, HotaB.Community-associated methicillin-resistant Staphylococcus aureus and HIV: intersecting epidemics. Clin Infect Dis 2010; 50: 979987.
  • 33
    Edge MD, RimlandD.Community-acquired bacteremia in HIV-positive patients: protective benefit of co-trimoxazole. AIDS 1996; 10: 16351639.
  • 34
    Wininger DA, FassRJ.Impact of trimethoprim-sulfamethoxazole prophylaxis on etiology and susceptibilities of pathogens causing human immunodeficiency virus-associated bacteremia. Antimicrob Agents Chemother2002; 46: 594597.
  • 35
    Styrt BA, ChaissonRE, MooreRD.Prior antimicrobials and staphylococcal bacteremia in HIV-infected patients. AIDS1997; 11: 12431248.
  • 36
    Cowan SA, SmithE.Incidence of HIV/AIDS in Denmark, 1990–2005. Ugeskr Laeger2006; 168: 22472252.